|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 400 out of 411 for Mycn

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.375s

Categories

Category: Publication
« show all
Type Details Score
Publication
- | J:293217
       
First Author: GemPharmatech
Year: 2020
Title: GemPharmatech Website.
•
•
•
•
•
Publication
21677750 | J:173534
First Author: Skarnes WC
Year: 2011
Journal: Nature
Title: A conditional knockout resource for the genome-wide study of mouse gene function.
Volume: 474
Issue: 7351
Pages: 337-42
•
•
•
•
•
Publication
- | J:141210
     
First Author: Mouse Genome Informatics (MGI) and National Center for Biotechnology Information (NCBI)
Year: 2008
Journal: Database Download
Title: Mouse Gene Trap Data Load from dbGSS
•
•
•
•
•
Publication
- | J:326541
       
First Author: Cyagen Biosciences Inc.
Year: 2022
Title: Cyagen Biosciences Website.
•
•
•
•
•
Publication
- | J:342605
       
First Author: GOA curators
Year: 2016
Title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
•
•
•
•
•
Publication
12466851 | J:80000
First Author: Okazaki Y
Year: 2002
Journal: Nature
Title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Volume: 420
Issue: 6915
Pages: 563-73
•
•
•
•
•
Publication
- | J:75000
       
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: Mouse Genome Informatics Computational Sequence to Gene Associations
•
•
•
•
•
Publication
- | J:57747
     
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort
•
•
•
•
•
Publication
27769070 | J:339434
First Author: Fielitz K
Year: 2016
Journal: Oncotarget
Title: Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.
Volume: 7
Issue: 46
Pages: 74415-74426
•
•
•
•
•
Publication
12880978 | J:85004
First Author: Hogarty MD
Year: 2003
Journal: Cancer Lett
Title: The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.
Volume: 197
Issue: 1-2
Pages: 173-9
•
•
•
•
•
Publication
17449239 | J:122306
First Author: Cheng AJ
Year: 2007
Journal: Eur J Cancer
Title: Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma.
Volume: 43
Issue: 9
Pages: 1467-75
•
•
•
•
•
Publication
38001143 | J:343065
First Author: Schoof M
Year: 2023
Journal: Nat Commun
Title: Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
Volume: 14
Issue: 1
Pages: 7717
•
•
•
•
•
Publication
19608868 | J:150780
First Author: Alam G
Year: 2009
Journal: Am J Pathol
Title: MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development.
Volume: 175
Issue: 2
Pages: 856-66
•
•
•
•
•
Publication
19047152 | J:142092
First Author: Hogarty MD
Year: 2008
Journal: Cancer Res
Title: ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.
Volume: 68
Issue: 23
Pages: 9735-45
•
•
•
•
•
Publication
17710228 | J:127480
First Author: Song L
Year: 2007
Journal: J Clin Invest
Title: Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
Volume: 117
Issue: 9
Pages: 2702-12
•
•
•
•
•
Publication
26068589 | J:258951
First Author: Petroni M
Year: 2016
Journal: Cell Death Differ
Title: The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress.
Volume: 23
Issue: 2
Pages: 197-206
•
•
•
•
•
Publication
28574509 | J:268301
First Author: Delaidelli A
Year: 2017
Journal: Cell Death Differ
Title: MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Volume: 24
Issue: 9
Pages: 1564-1576
•
•
•
•
•
Publication
8174136 | J:18224
First Author: Ferrandis E
Year: 1994
Journal: Cancer Res
Title: Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
Volume: 54
Issue: 8
Pages: 2256-61
•
•
•
•
•
Publication
36869047 | J:333935
First Author: Mainwaring OJ
Year: 2023
Journal: Nat Commun
Title: ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Volume: 14
Issue: 1
Pages: 1221
•
•
•
•
•
Publication
22907398 | J:193509
First Author: Schramm A
Year: 2013
Journal: Int J Cancer
Title: Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Volume: 132
Issue: 3
Pages: E106-15
•
•
•
•
•
Publication
24391509 | J:226671
First Author: Suenaga Y
Year: 2014
Journal: PLoS Genet
Title: NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.
Volume: 10
Issue: 1
Pages: e1003996
•
•
•
•
•
Publication
11861392 | -
First Author: Shohet JM
Year: 2002
Journal: Cancer Res
Title: Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
Volume: 62
Issue: 4
Pages: 1123-8
•
•
•
•
•
Publication
10882752 | -
First Author: Frühwald MC
Year: 2000
Journal: J Med Genet
Title: Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
Volume: 37
Issue: 7
Pages: 501-9
•
•
•
•
•
Publication
9516855 | -
First Author: Ross RA
Year: 1997
Journal: Eur J Cancer
Title: HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
Volume: 33
Issue: 12
Pages: 2071-4
•
•
•
•
•
Publication
25174395 | J:222527
First Author: Althoff K
Year: 2015
Journal: Oncogene
Title: A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.
Volume: 34
Issue: 26
Pages: 3357-68
•
•
•
•
•
Publication
25533335 | J:218831
First Author: Hill RM
Year: 2015
Journal: Cancer Cell
Title: Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Volume: 27
Issue: 1
Pages: 72-84
•
•
•
•
•
Publication
25294817 | J:317516
First Author: Beckers A
Year: 2015
Journal: Oncotarget
Title: MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.
Volume: 6
Issue: 7
Pages: 5204-16
•
•
•
•
•
Publication
35508126 | J:325007
First Author: Trieu KG
Year: 2022
Journal: Cell Rep
Title: Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.
Volume: 39
Issue: 5
Pages: 110779
•
•
•
•
•
Publication
34099734 | J:307910
First Author: Brady NJ
Year: 2021
Journal: Nat Commun
Title: Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
Volume: 12
Issue: 1
Pages: 3372
•
•
•
•
•
Publication
26766585 | J:231324
First Author: Mathsyaraja H
Year: 2016
Journal: Cancer Cell
Title: Parsing Myc Paralogs in Oncogenesis.
Volume: 29
Issue: 1
Pages: 1-2
•
•
•
•
•
Publication
38636893 | J:350799
 
First Author: Zhuo R
Year: 2024
Journal: Cancer Lett
Title: CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma.
Volume: 591
Pages: 216882
•
•
•
•
•
Publication
23475876 | J:198393
First Author: Schnepp RW
Year: 2013
Journal: Cancer Discov
Title: Targeting MYCN: a good BET for improving neuroblastoma therapy?
Volume: 3
Issue: 3
Pages: 255-7
•
•
•
•
•
Publication
36219398 | J:332175
First Author: Borgenvik A
Year: 2022
Journal: Cancer Res
Title: Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Volume: 82
Issue: 24
Pages: 4586-4603
•
•
•
•
•
Publication
22340591 | J:181462
First Author: Kawauchi D
Year: 2012
Journal: Cancer Cell
Title: A mouse model of the most aggressive subgroup of human medulloblastoma.
Volume: 21
Issue: 2
Pages: 168-80
•
•
•
•
•
Publication
27050099 | J:231826
First Author: Lee JK
Year: 2016
Journal: Cancer Cell
Title: N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
Volume: 29
Issue: 4
Pages: 536-547
•
•
•
•
•
Publication
27396325 | J:238681
First Author: Ribeiro D
Year: 2016
Journal: Cell Rep
Title: Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.
Volume: 16
Issue: 4
Pages: 979-993
•
•
•
•
•
Publication
26766587 | J:231323
First Author: Vo BT
Year: 2016
Journal: Cancer Cell
Title: The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.
Volume: 29
Issue: 1
Pages: 5-16
•
•
•
•
•
Publication
38016952 | J:360598
First Author: Ji Y
Year: 2023
Journal: Nat Commun
Title: The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer.
Volume: 14
Issue: 1
Pages: 7794
•
•
•
•
•
Publication
30315164 | J:267604
First Author: Singh BN
Year: 2018
Journal: Nat Commun
Title: A conserved HH-Gli1-Mycn network regulates heart regeneration from newt to human.
Volume: 9
Issue: 1
Pages: 4237
•
•
•
•
•
Publication
28637693 | J:245948
First Author: Fell SM
Year: 2017
Journal: Genes Dev
Title: Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.
Volume: 31
Issue: 10
Pages: 1036-1053
•
•
•
•
•
Publication
15743832 | J:97664
First Author: Cardone M
Year: 2005
Journal: Mol Cell Biol
Title: The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
Volume: 25
Issue: 6
Pages: 2395-405
•
•
•
•
•
Publication
24465765 | J:212335
First Author: Smith S
Year: 2014
Journal: PLoS One
Title: LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
Volume: 9
Issue: 1
Pages: e85883
•
•
•
•
•
Publication
26537256 | J:234050
First Author: Carter DR
Year: 2015
Journal: Sci Transl Med
Title: Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.
Volume: 7
Issue: 312
Pages: 312ra176
•
•
•
•
•
Publication
23243020 | J:194367
First Author: Kishida S
Year: 2013
Journal: Cancer Res
Title: Midkine promotes neuroblastoma through Notch2 signaling.
Volume: 73
Issue: 4
Pages: 1318-27
•
•
•
•
•
Publication
28739902 | J:244650
First Author: Dyberg C
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Rho-associated kinase is a therapeutic target in neuroblastoma.
Volume: 114
Issue: 32
Pages: E6603-E6612
•
•
•
•
•
Publication
23792191 | J:199151
First Author: Brockmann M
Year: 2013
Journal: Cancer Cell
Title: Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma.
Volume: 24
Issue: 1
Pages: 75-89
•
•
•
•
•
Publication
33768209 | J:313873
First Author: Roeschert I
Year: 2021
Journal: Nat Cancer
Title: Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma.
Volume: 2
Issue: 3
Pages: 312-326
•
•
•
•
•
Publication
37696947 | J:341095
First Author: Collignon E
Year: 2023
Journal: Nat Cell Biol
Title: m(6)A RNA methylation orchestrates transcriptional dormancy during paused pluripotency.
Volume: 25
Issue: 9
Pages: 1279-1289
•
•
•
•
•
Publication
26597947 | J:233968
First Author: Borriello L
Year: 2016
Journal: Cancer Lett
Title: More than the genes, the tumor microenvironment in neuroblastoma.
Volume: 380
Issue: 1
Pages: 304-14
•
•
•
•
•
Publication
31375684 | J:279483
First Author: Dammert MA
Year: 2019
Journal: Nat Commun
Title: MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer.
Volume: 10
Issue: 1
Pages: 3485
•
•
•
•
•
Publication
38992040 | J:351291
First Author: Murray JE
Year: 2024
Journal: Nat Commun
Title: The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
Volume: 15
Issue: 1
Pages: 5585
•
•
•
•
•
Publication
29492199 | J:320562
First Author: De Wilde B
Year: 2018
Journal: Oncotarget
Title: The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease.
Volume: 9
Issue: 9
Pages: 8334-8349
•
•
•
•
•
Publication
9931502 | J:52533
First Author: Sugiyama A
Year: 1999
Journal: Gene
Title: Molecular cloning and chromosomal mapping of mouse intronless myc gene acting as a potent apoptosis inducer.
Volume: 226
Issue: 2
Pages: 273-83
•
•
•
•
•
Publication
11525062 | J:71144
First Author: Yamasaki Y
Year: 2001
Journal: Hereditas
Title: Mouse chromosome 19 and distal rat chromosome 1: a chromosome segment conserved in evolution.
Volume: 134
Issue: 1
Pages: 23-34
•
•
•
•
•
Publication
12438760 | J:80791
First Author: Shan ZH
Year: 2002
Journal: Cytogenet Genome Res
Title: Reassignment of Mycs gene to mouse chromosome XA1.2-2 by radiation hybrid mapping and fluorescence in situ hybridization.
Volume: 97
Issue: 1-2
Pages: 140G
•
•
•
•
•
Publication
16288218 | J:305714
First Author: Machida T
Year: 2006
Journal: Oncogene
Title: Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Volume: 25
Issue: 13
Pages: 1931-42
•
•
•
•
•
Publication
24928431 | J:214730
First Author: Zindy F
Year: 2014
Journal: Biol Open
Title: Role of the miR-17∼92 cluster family in cerebellar and medulloblastoma development.
Volume: 3
Issue: 7
Pages: 597-605
•
•
•
•
•
Publication
22020437 | J:180692
First Author: Choi YJ
Year: 2011
Journal: Nat Cell Biol
Title: miR-34 miRNAs provide a barrier for somatic cell reprogramming.
Volume: 13
Issue: 11
Pages: 1353-60
•
•
•
•
•
Publication
29321660 | J:261033
First Author: Lopez-Delisle L
Year: 2018
Journal: Oncogene
Title: Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis.
Volume: 37
Issue: 11
Pages: 1417-1429
•
•
•
•
•
Publication
31218818 | J:294092
First Author: Ono S
Year: 2019
Journal: Genesis
Title: Generation of conditional ALK F1174L mutant mouse models for the study of neuroblastoma pathogenesis.
Volume: 57
Issue: 10
Pages: e23323
•
•
•
•
•
Publication
32071205 | J:285751
First Author: Anderson DA 3rd
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
Volume: 117
Issue: 9
Pages: 4885-4893
•
•
•
•
•
Publication
22764207 | J:186696
First Author: Heukamp LC
Year: 2012
Journal: Sci Transl Med
Title: Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.
Volume: 4
Issue: 141
Pages: 141ra91
•
•
•
•
•
Publication
24811913 | J:228124
First Author: Cazes A
Year: 2014
Journal: Oncotarget
Title: Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
Volume: 5
Issue: 9
Pages: 2688-702
•
•
•
•
•
Publication
30213853 | J:265919
First Author: Singh HP
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.
Volume: 115
Issue: 40
Pages: E9391-E9400
•
•
•
•
•
Publication
23536557 | J:198365
First Author: Teitz T
Year: 2013
Journal: Cancer Res
Title: Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.
Volume: 73
Issue: 13
Pages: 4086-97
•
•
•
•
•
Publication
17909053 | J:125649
First Author: Chesler L
Year: 2007
Journal: Cancer Res
Title: Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Volume: 67
Issue: 19
Pages: 9435-42
•
•
•
•
•
Publication
34826366 | J:325536
First Author: Gifford AJ
Year: 2021
Journal: Curr Protoc
Title: A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma.
Volume: 1
Issue: 11
Pages: e310
•
•
•
•
•
Publication
17392175 | J:120132
First Author: Cui H
Year: 2007
Journal: Am J Pathol
Title: Bmi-1 is essential for the tumorigenicity of neuroblastoma cells.
Volume: 170
Issue: 4
Pages: 1370-8
•
•
•
•
•
Publication
29610116 | J:262586
First Author: Ooi CY
Year: 2018
Journal: Cancer Res
Title: Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
Volume: 78
Issue: 12
Pages: 3122-3134
•
•
•
•
•
Publication
26471359 | J:226765
First Author: Sun Y
Year: 2015
Journal: Cancer Res
Title: WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Volume: 75
Issue: 23
Pages: 5143-54
•
•
•
•
•
Publication
26914605 | J:234424
First Author: Waldeck K
Year: 2016
Journal: Int J Cancer
Title: Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.
Volume: 139
Issue: 1
Pages: 194-204
•
•
•
•
•
Publication
22202125 | J:181234
First Author: Fletcher JI
Year: 2012
Journal: Cancer Res
Title: N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.
Volume: 72
Issue: 4
Pages: 845-53
•
•
•
•
•
Publication
20298674 | J:159225
First Author: Asano Y
Year: 2010
Journal: Biochem Biophys Res Commun
Title: DRR1 is expressed in the developing nervous system and downregulated during neuroblastoma carcinogenesis.
Volume: 394
Issue: 3
Pages: 829-35
•
•
•
•
•
Publication
10811128 | J:62146
First Author: Weiss WA
Year: 2000
Journal: Cancer Res
Title: Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
Volume: 60
Issue: 9
Pages: 2483-7
•
•
•
•
•
Publication
21349947 | J:170996
First Author: Huang P
Year: 2011
Journal: Cancer Res
Title: The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma.
Volume: 71
Issue: 8
Pages: 2938-48
•
•
•
•
•
Publication
37958555 | J:342589
 
First Author: Zhai L
Year: 2023
Journal: Int J Mol Sci
Title: Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.
Volume: 24
Issue: 21
•
•
•
•
•
Publication
26123663 | J:222998
First Author: Beckers A
Year: 2015
Journal: Cancer Lett
Title: MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.
Volume: 366
Issue: 1
Pages: 123-32
•
•
•
•
•
Publication
25348795 | J:221990
First Author: Thor T
Year: 2015
Journal: Int J Cancer
Title: MiR-34a deficiency accelerates medulloblastoma formation in vivo.
Volume: 136
Issue: 10
Pages: 2293-303
•
•
•
•
•
Publication
19020752 | J:156984
First Author: Iwakura H
Year: 2008
Journal: Int J Oncol
Title: Establishment of a novel neuroblastoma mouse model.
Volume: 33
Issue: 6
Pages: 1195-9
•
•
•
•
•
Publication
14500357 | J:85511
First Author: Hackett CS
Year: 2003
Journal: Cancer Res
Title: Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.
Volume: 63
Issue: 17
Pages: 5266-73
•
•
•
•
•
Publication
16012519 | J:100284
First Author: Liu T
Year: 2005
Journal: Br J Cancer
Title: The retinoid anticancer signal: mechanisms of target gene regulation.
Volume: 93
Issue: 3
Pages: 310-8
•
•
•
•
•
Publication
15923078 | J:100622
First Author: Giannini G
Year: 2005
Journal: Cancer Lett
Title: Molecular mechanism of HMGA1 deregulation in human neuroblastoma.
Volume: 228
Issue: 1-2
Pages: 97-104
•
•
•
•
•
Publication
19893043 | J:155323
First Author: Xia SJ
Year: 2009
Journal: Am J Pathol
Title: High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts.
Volume: 175
Issue: 6
Pages: 2600-8
•
•
•
•
•
Publication
21945349 | J:178546
First Author: Azarova AM
Year: 2011
Journal: Semin Cancer Biol
Title: Emerging importance of ALK in neuroblastoma.
Volume: 21
Issue: 4
Pages: 267-75
•
•
•
•
•
Publication
22706201 | J:191038
First Author: Cascón A
Year: 2012
Journal: Cancer Res
Title: MAX and MYC: a heritable breakup.
Volume: 72
Issue: 13
Pages: 3119-24
•
•
•
•
•
Publication
23671190 | J:204479
First Author: Berenguer J
Year: 2013
Journal: Mol Cell Biol
Title: MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.
Volume: 33
Issue: 14
Pages: 2706-17
•
•
•
•
•
Publication
22936790 | J:205382
First Author: Buechner J
Year: 2012
Journal: Mol Cancer Res
Title: N-myc and noncoding RNAs in neuroblastoma.
Volume: 10
Issue: 10
Pages: 1243-53
•
•
•
•
•
Publication
27880818 | J:247365
First Author: Berrios C
Year: 2016
Journal: PLoS Pathog
Title: Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation.
Volume: 12
Issue: 11
Pages: e1006020
•
•
•
•
•
Publication
29686061 | J:262068
First Author: Qin XY
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
Volume: 115
Issue: 19
Pages: 4969-4974
•
•
•
•
•
Publication
29941555 | J:263854
First Author: Pieraccioli M
Year: 2018
Journal: Proc Natl Acad Sci U S A
Title: ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Volume: 115
Issue: 28
Pages: 7356-7361
•
•
•
•
•
Publication
31560547 | J:295874
First Author: Hsieh CH
Year: 2019
Journal: J Proteome Res
Title: Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM To Suppress Neuroblastoma Progression.
Volume: 18
Issue: 11
Pages: 3850-3866
•
•
•
•
•
Publication
33500353 | J:302050
 
First Author: Hanemaaijer ES
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
Volume: 118
Issue: 5
•
•
•
•
•
Publication
33658627 | J:303943
First Author: Cheung BB
Year: 2021
Journal: Oncogene
Title: A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.
Volume: 40
Issue: 13
Pages: 2367-2381
•
•
•
•
•
Publication
36831211 | J:333752
 
First Author: Ando K
Year: 2023
Journal: Cells
Title: The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.
Volume: 12
Issue: 4
•
•
•
•
•
Publication
38176167 | J:344410
 
First Author: Kwon Y
Year: 2024
Journal: Mol Immunol
Title: HDAC6-MYCN-CXCL3 axis mediates allergic inflammation and is necessary for allergic inflammation-promoted cellular interactions.
Volume: 166
Pages: 1-15
•
•
•
•
•
Publication
29769563 | J:262736
First Author: Renard M
Year: 2018
Journal: Sci Rep
Title: Expressed repetitive elements are broadly applicable reference targets for normalization of reverse transcription-qPCR data in mice.
Volume: 8
Issue: 1
Pages: 7642
•
•
•
•
•
Publication
19070574 | J:145691
First Author: Robbiani DF
Year: 2008
Journal: Cell
Title: AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.
Volume: 135
Issue: 6
Pages: 1028-38
•
•
•
•
•
Publication
35145326 | J:330715
First Author: Hirano M
Year: 2022
Journal: Nat Metab
Title: MYCL-mediated reprogramming expands pancreatic insulin-producing cells.
Volume: 4
Issue: 2
Pages: 254-268
•
•
•
•
•
Publication
23284678 | J:195635
First Author: Rasmuson A
Year: 2012
Journal: PLoS One
Title: Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.
Volume: 7
Issue: 12
Pages: e51297
•
•
•
•
•
Publication
25901736 | J:233472
First Author: Vaillant C
Year: 2015
Journal: PLoS One
Title: Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Volume: 10
Issue: 4
Pages: e0124870
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom